Skip to search.
 TSX Up0.84% TSX Ventures 0.00%

Sagent Pharmaceuticals, Inc. (SGNT)

-NasdaqGM

16.28 Up 0.34(2.13%) May 17, 4:00PM EDT|After Hours : 16.27 Down 0.01 (0.06%) May 17, 7:08PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 183,615   152,405   74,056  
Cost of Revenue152,508  133,636  65,013  
Gross Profit 31,107   18,769   9,043  
Operating Expenses
Research Development17,136  12,763  11,223  
Selling General and Administrative30,093  25,148  18,931  
Non Recurring708   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (15,493) (21,673) (22,587)
Income from Continuing Operations
Total Other Income/Expenses Net243  (554)(779)
Earnings Before Interest And Taxes(15,250)(22,227)(23,366)
Interest Expense1,567  4,195  1,129  
Income Before Tax(16,817)(26,422)(24,495)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(15,480)(28,953)(25,971)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (16,817) (26,422) (24,495)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (16,817) (26,422) (24,495)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.